Valirx Plc Is A Biopharmaceutical Company Based In The Ukfocused On Developing Oncology Therapeutics And Diagnosticsfounded In 2000 And Headquartered In Nuneatonvalirx Specializes In Clinical Stage Cancer Treatments And Operates Under The Biotechnology R&D Sectorthe Company Utilizes Its Proprietary Geneice Technology To Create Targeted Therapies That Silence Disease Causing Genes Valirx S Product Lineup Includes Several Key Treatmentsval201 For Hormone Induced Refractory Prostate Cancerval401 For Pancreatic Ductal Adenocarcinomaval301 For Endometriosisbc201 For Hyperimmune Responses Post Sars Cov 2 Infectionand Clx001 For Triple Negative Breast Canceradditionallythe Company Offers The Nav3 Cancer Screening Test And Has Eight Pipeline Drugs In Developmentvalirx Also Has Divisions Such As Valimedixwhich Distributes Oncology Therapeuticsvalipharmawhich Provides Cancer Treatment Technologiesand Valifinnwhich Offers R&D Services Including Clinical Trial Developmentthe Company Actively Manages Clinical Trials And Tracks Drug Development Milestones To Enhance Its Operations
No conferences found for this company.
| Company Name | Valiseek Ltd |
| Country |
United Kingdom
|
| Address | N/A |
| Telephone | N/A |
| N/A |
